Sign In

Login

Password

Forgot Password ? Sign Up

Sarkosin (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Sarkosin" in Czech language version.

refsWebsite
Global rank Czech rank
10nih.gov
4th place
8th place
9doi.org
2nd place
4th place
1clinicaltrials.gov
5,225th place
2,661st place
1umich.edu
459th place
340th place
1harvard.edu
18th place
99th place
1sciencemag.org
857th place
315th place
1web.archive.org
1st place
1st place
1cdlib.org
2,268th place
4,219th place

cdlib.org

publishing.cdlib.org

clinicaltrials.gov

  • N-methylglycine (Sarcosine) Treatment for Depression - Full Text View - ClinicalTrials.gov [online]. [cit. 2018-04-06]. Dostupné online. 

doi.org

dx.doi.org

  • Allen RH, Stabler SP, Lindenbaum J. Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism. Metabolism. November 1993, s. 1448–60. DOI 10.1016/0026-0495(93)90198-W. PMID 7694037. 
  • Lane HY, Huang CL, Wu PL, Liu YC, Chang YC, Lin PY, Chen PW, Tsai G. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia. Biological Psychiatry. September 2006, s. 645–9. DOI 10.1016/j.biopsych.2006.04.005. PMID 16780811. 
  • Tsai G, Lane HY, Yang P, Chong MY, Lange N. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia. Biological Psychiatry. March 2004, s. 452–6. DOI 10.1016/j.biopsych.2003.09.012. PMID 15023571. 
  • Singh SP, Singh V. Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia. CNS Drugs. October 2011, s. 859–85. DOI 10.2165/11586650-000000000-00000. PMID 21936588. 
  • Huang CC, Wei IH, Huang CL, Chen KT, Tsai MH, Tsai P, Tun R, Huang KH, Chang YC, Lane HY, Tsai GE. Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression. Biological Psychiatry. November 2013, s. 734–41. DOI 10.1016/j.biopsych.2013.02.020. PMID 23562005. 
  • Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. February 2009, s. 910–4. Dostupné online. DOI 10.1038/nature07762. PMID 19212411. Bibcode 2009Natur.457..910S. 
  • Jentzmik F, Stephan C, Miller K, Schrader M, Erbersdobler A, Kristiansen G, Lein M, Jung K. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. European Urology. July 2010, s. 12–8; discussion 20–1. DOI 10.1016/j.eururo.2010.01.035. PMID 20117878. 
  • Struys EA, Heijboer AC, van Moorselaar J, Jakobs C, Blankenstein MA. Serum sarcosine is not a marker for prostate cancer. Annals of Clinical Biochemistry. May 2010, s. 282. DOI 10.1258/acb.2010.009270. PMID 20233752. 
  • Pavlou M, Diamandis EP. The search for new prostate cancer biomarkers continues. Clinical Chemistry. July 2009, s. 1277–9. DOI 10.1373/clinchem.2009.126870. PMID 19478024. 

harvard.edu

adsabs.harvard.edu

  • Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. February 2009, s. 910–4. Dostupné online. DOI 10.1038/nature07762. PMID 19212411. Bibcode 2009Natur.457..910S. 

nih.gov

ncbi.nlm.nih.gov

  • Allen RH, Stabler SP, Lindenbaum J. Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism. Metabolism. November 1993, s. 1448–60. DOI 10.1016/0026-0495(93)90198-W. PMID 7694037. 
  • Lane HY, Huang CL, Wu PL, Liu YC, Chang YC, Lin PY, Chen PW, Tsai G. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia. Biological Psychiatry. September 2006, s. 645–9. DOI 10.1016/j.biopsych.2006.04.005. PMID 16780811. 
  • Tsai G, Lane HY, Yang P, Chong MY, Lange N. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia. Biological Psychiatry. March 2004, s. 452–6. DOI 10.1016/j.biopsych.2003.09.012. PMID 15023571. 
  • Singh SP, Singh V. Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia. CNS Drugs. October 2011, s. 859–85. DOI 10.2165/11586650-000000000-00000. PMID 21936588. 
  • Huang CC, Wei IH, Huang CL, Chen KT, Tsai MH, Tsai P, Tun R, Huang KH, Chang YC, Lane HY, Tsai GE. Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression. Biological Psychiatry. November 2013, s. 734–41. DOI 10.1016/j.biopsych.2013.02.020. PMID 23562005. 
  • Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. February 2009, s. 910–4. Dostupné online. DOI 10.1038/nature07762. PMID 19212411. Bibcode 2009Natur.457..910S. 
  • Jentzmik F, Stephan C, Miller K, Schrader M, Erbersdobler A, Kristiansen G, Lein M, Jung K. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. European Urology. July 2010, s. 12–8; discussion 20–1. DOI 10.1016/j.eururo.2010.01.035. PMID 20117878. 
  • Struys EA, Heijboer AC, van Moorselaar J, Jakobs C, Blankenstein MA. Serum sarcosine is not a marker for prostate cancer. Annals of Clinical Biochemistry. May 2010, s. 282. DOI 10.1258/acb.2010.009270. PMID 20233752. 
  • Pavlou M, Diamandis EP. The search for new prostate cancer biomarkers continues. Clinical Chemistry. July 2009, s. 1277–9. DOI 10.1373/clinchem.2009.126870. PMID 19478024. 

pubchem.ncbi.nlm.nih.gov

  • Sarcosine. pubchem.ncbi.nlm.nih.gov [online]. PubChem [cit. 2021-05-24]. Dostupné online. (anglicky) 

sciencemag.org

sciencenow.sciencemag.org

umich.edu

deepblue.lib.umich.edu

  • Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. February 2009, s. 910–4. Dostupné online. DOI 10.1038/nature07762. PMID 19212411. Bibcode 2009Natur.457..910S. 

web.archive.org